Our study demonstrated a previously unrecognized pathway in YAP-induced cholangiocarcinogenesis and metastasis, which suggested therapeutic targets, including YAP, IGF1, AKT, and gankyrin, in CCA prevention and treatment. The gene discussed is IGF1; the disease is cholangiocarcinoma.